Literature DB >> 8884805

Supportive nutritional management of the patient with pancreatic cancer.

F Ottery1.   

Abstract

Progressive weight loss and nutritional deterioration are commonly found in the patient with pancreatic cancer. The combined effects of the central anatomic location of the pancreas, endocrine and exocrine hormonal insufficiency, and treatment toxicity place patients with pancreatic cancer at high risk for developing symptoms that affect their ability to consume and absorb adequate calories and protein. The use of standardized nutritional assessment and an algorithmic approach for nutritional intervention fosters determination of the patient's nutritional risk status early in the course of disease, fosters early detection of treatable symptoms that interfere with nutritional intake/absorption, and can assess the effect of nutritional interventions. Supportive nutritional efforts can decrease complications, shorten hospital stays, reduce costs, and improve the patient's sense of well-being.

Entities:  

Mesh:

Year:  1996        PMID: 8884805

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

Review 1.  Managing cancer-related anorexia/cachexia.

Authors:  G Mantovani; A Macciò; E Massa; C Madeddu
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Feeding patients following pancreaticoduodenectomy: a UK national survey.

Authors:  Mary Phillips; Jeffrey T Lordan; Neville Menezes; Nariman D Karanjia
Journal:  Ann R Coll Surg Engl       Date:  2009-04-30       Impact factor: 1.891

Review 3.  Pancreatic cancer cachexia: a review of mechanisms and therapeutics.

Authors:  Carlyn R Tan; Patrick M Yaffee; Laith H Jamil; Simon K Lo; Nicholas Nissen; Stephen J Pandol; Richard Tuli; Andrew E Hendifar
Journal:  Front Physiol       Date:  2014-03-03       Impact factor: 4.566

Review 4.  Pancreas Cancer-Associated Weight Loss.

Authors:  Andrew E Hendifar; Maria Q B Petzel; Teresa A Zimmers; Crystal S Denlinger; Lynn M Matrisian; Vincent J Picozzi; Lola Rahib
Journal:  Oncologist       Date:  2018-12-27       Impact factor: 5.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.